Chordia Therapeutics (TSE:190A) Days Inventory: 0.00 (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:190A Chordia Therapeutics Inc TSE:190A
11 GF Score
Price 円77.00
! 1 Warning Sign
View Full Analysis

What is Chordia Therapeutics Days Inventory?

Chordia Therapeutics TSE:190A -2.53% 11 Days Inventory is 0.00 as of Feb. 2026. GuruFocus rates TSE:190A with a GF Score™ of 11/100. The stock has 1 warning sign investors should review. Among 638 Biotechnology companies, Chordia Therapeutics ranks worse than 156739.66% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). Chordia Therapeutics's Average Total Inventories for the six months ended in Feb. 2026 was 円0.00 Mil. Chordia Therapeutics's Cost of Goods Sold for the six months ended in Feb. 2026 was 円510.33 Mil. Hence, Chordia Therapeutics's Days Inventory for the six months ended in Feb. 2026 was 0.00.

The historical rank and industry rank for Chordia Therapeutics's Days Inventory or its related term are showing as below:

TSE:190A's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 183.195
* Ranked among companies with meaningful Days Inventory only.

Chordia Therapeutics's Days Inventory stayed the same from Feb. 2025 (0.00) to Feb. 2026 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Chordia Therapeutics  (TSE:190A) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Chordia Therapeutics's Inventory Turnover for the six months ended in Feb. 2026 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Chordia Therapeutics's Inventory to Revenue for the six months ended in Feb. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Chordia Therapeutics Days Inventory Related Terms


Chordia Therapeutics Days Inventory Historical Data

* Premium members only.

The historical data trend for Chordia Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chordia Therapeutics Days Inventory Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24 Aug25
Days Inventory
0.00 0.00 0.00 0.00 0.00

Chordia Therapeutics Semi-Annual Data
Aug21 Aug22 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Days Inventory Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

TSE:190A vs VRTX, REGN, ALNY: Days Inventory Comparison

For the Biotechnology subindustry, Chordia Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chordia Therapeutics Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chordia Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Chordia Therapeutics's Days Inventory falls into.


TSE:190A
11GF Score
Chordia Therapeutics Inc TSE:190A
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chordia Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Chordia Therapeutics's Days Inventory for the fiscal year that ended in Aug. 2025 is calculated as

Days Inventory (A: Aug. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Aug. 2024 ) + Total Inventories (A: Aug. 2025 )) / count ) / Cost of Goods Sold (A: Aug. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 1425.309*365
=0 / 1425.309*365
=0.00

Chordia Therapeutics's Days Inventory for the quarter that ended in Feb. 2026 is calculated as:

Days Inventory (Q: Feb. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Aug. 2025 ) + Total Inventories (Q: Feb. 2026 )) / count ) / Cost of Goods Sold (Q: Feb. 2026 )*Days in Period
=( (0 + 0) / 1 ) / 510.333*365 / 2
=0 / 510.333*365 / 2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 0.00 mean?
Chordia Therapeutics (TSE:190A) has a Days Inventory of 0.00 as of Feb. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Chordia Therapeutics and its competitors. According to the industry distribution chart, Chordia Therapeutics ranks #999999 out of 638 companies in the Biotechnology industry.
Is Chordia Therapeutics' Days Inventory too high?
Chordia Therapeutics' current Days Inventory is 0.00. Based on the distribution chart, Chordia Therapeutics ranks #999999 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Chordia Therapeutics has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Chordia Therapeutics' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chordia Therapeutics ranks #999999 out of 638 companies for Days Inventory. This places Chordia Therapeutics in the lower half of its industry. The industry median Days Inventory is 183.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Chordia Therapeutics and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chordia Therapeutics's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chordia Therapeutics stock overvalued right now?
Chordia Therapeutics (TSE:190A) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Chordia Therapeutics' overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Chordia Therapeutics (TSE:190A), the current Days Inventory is 0.00 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chordia Therapeutics Business Description

Address 2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.
11GF Score

Get the complete analysis for TSE:190A

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円77.00
Price